Abstract
Background Multi-drug resistant Enterobacterales, in particular with ceftriaxone resistance (CefR-E), are globally prevalent. Pregnant people colonized with resistant Enterobacterales are at risk of perinatally transmitting to neonates; infections with CefR-E strains are associated with higher mortality, morbidity and health care costs. This study aimed to estimate the rate of gut colonization of AmpR-E (ampicillin resistant Enterobacterales) and CefR-E in a population of healthy mother-infant dyads in the Chicago area and investigate the genetic characteristics of CefR-E.
Methods Pregnant persons anticipating vaginal birth at two Chicago area hospitals were enrolled. Patients with preterm delivery (<35 weeks), fever during labor, cesarean delivery, exposure to antibiotics in 3rd trimester, and neonatal intensive care were excluded. Pregnancy and birth history were obtained from parent and medical record. Maternal vaginal and rectal swabs, and infant stool samples were collected and screened for resistance by plating on MacConkey with ceftriaxone. Whole genome sequencing (WGS) and analysis was conducted on the CefR-E isolates.
Results Between July 2020 and April 2022, 261 mother-infant dyads were enrolled with 184 maternal samples and 157 infant stool samples analyzed. Rate of maternal AmpR-E gut colonization was 97% (179/184). Rate of maternal and infant CefR-E gut colonization was 14% (26/184) and 7% (11/157) respectively. Perinatal transmission of CefR-E was 50% (11 of 22) positive mothers with available infant sample). No clinical variables were significantly associated with maternal CefR-E colonization or perinatal transmission. Type of infant nutrition (breastmilk) was significantly associated with decreased perinatal transmission of AmpR-E to infant (p=0.015). WGS of the CefR-E showed that 19/42 isolates were E. coli, and transmission primarily occurred from mothers colonized with E. coli.
Conclusions This study demonstrates that a sizable minority of pregnant persons are colonized with CefR-E in the U.S., a higher burden than previously reported for developed countries. Enterobacterales appear adept in perinatal transmission, with half of infants born to colonized pregnant persons harboring CefR-E in first week of life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a Dixon Translational Research Grant and the Buffet Institute at Northwestern University. Additional salary support from NIH/NIAID K23 AI139337 (LBM) and K08AI123524 (MA).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRBs of Northwestern University and Lurie Children's Hospital gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
